Genmab — April 2016
-
Novod: The strong launch of Darzalex of course also raises the natural M&A question, in particular with recent news of Medivation being in play
-
nice - det er svært at bevare pessimismen
-
Novod siger han gætter, det kan være mere end 105m
-
og europa skulle gerne nå at hjælpe lidt med...
-
gad vide hvor lang tid det vil tage JJ at lave castor-ansøgningen?
-
det er sørme godt nok hurtigt! Men der er jo også godkendelseprocessen efterfølgende - så komboen kommer nok ikke til at hjælpe afgørende til med salget i år
-
hvad var other oncology i Q1 2015 og Q4 2015 ?
-
Q4 var 29.3
-
hvot darxalex på 19.7 var trukket fra
-
Other oncology var 49m i Q4 (incl Darzalex)
-
Ja så Darzalex er nok et sted mellem 105 og 115 ? realistisk set
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind